Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Penack

Showing results (161-170 of 184) with videos related to

Pageof 19
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2010
Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host diseaseSydney X Lu, Amanda M Holland, Il-Kang Na, et al.
Bone Marrow Transplantation|April 17, 2025
The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMTMustafa Güven, Christophe Peczynski, William Boreland, et al.
The Lancet Regional Health. Europe|February 20, 2025
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignanciesMichael Sandherr, Jannik Stemler, Enrico Schalk, et al.
Frontiers in Immunology|February 19, 2021
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell MalignanciesAgnieszka Tomaszewska, Madan Jagasia, Eric Beohou, et al.
Leukemia|November 20, 2024
Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT studyGuillermo Ortí, Christophe Peczynski, William Boreland, et al.
Bone Marrow Transplantation|September 10, 2025
Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working PartyAgnieszka Piekarska, Mouad Abouqateb, William Boreland, et al.
Blood|March 22, 2022
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in GermanyWolfgang A Bethge, Peter Martus, Michael Schmitt, et al.
Transplantation and Cellular Therapy|June 6, 2022
Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task ForceGeoffrey D E Cuvelier, Michelle Schoettler, Nataliya P Buxbaum, et al.
Frontiers in Immunology|January 23, 2026
m-EASIX (better than EASIX) predicts severe CAR T-cell toxicities, worse overall survival, and discriminates cytokine release syndrome from sepsisAna Belén Moreno-Castaño, Sara Fernández, Helena Brillembourg, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2019
Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn)Jon Salmanton-García, Danila Seidel, Philipp Koehler, et al.
Pageof 19

Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2010
Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host diseaseSydney X Lu, Amanda M Holland, Il-Kang Na, et al.
Bone Marrow Transplantation|April 17, 2025
The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMTMustafa Güven, Christophe Peczynski, William Boreland, et al.
The Lancet Regional Health. Europe|February 20, 2025
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignanciesMichael Sandherr, Jannik Stemler, Enrico Schalk, et al.
Frontiers in Immunology|February 19, 2021
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell MalignanciesAgnieszka Tomaszewska, Madan Jagasia, Eric Beohou, et al.
Leukemia|November 20, 2024
Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT studyGuillermo Ortí, Christophe Peczynski, William Boreland, et al.
Bone Marrow Transplantation|September 10, 2025
Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working PartyAgnieszka Piekarska, Mouad Abouqateb, William Boreland, et al.
Blood|March 22, 2022
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in GermanyWolfgang A Bethge, Peter Martus, Michael Schmitt, et al.
Transplantation and Cellular Therapy|June 6, 2022
Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task ForceGeoffrey D E Cuvelier, Michelle Schoettler, Nataliya P Buxbaum, et al.
Frontiers in Immunology|January 23, 2026
m-EASIX (better than EASIX) predicts severe CAR T-cell toxicities, worse overall survival, and discriminates cytokine release syndrome from sepsisAna Belén Moreno-Castaño, Sara Fernández, Helena Brillembourg, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2019
Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn)Jon Salmanton-García, Danila Seidel, Philipp Koehler, et al.
Pageof 19